Annual Secretarial Compliance report for the year ended March 31, 2026
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript for Earnings call- Q4- FY 2025-26
Earnings call for Q4(2025-26)
Press release regarding receipt of final approval by our subsidiary, Caplin Steriles Limited, from USFDA, for Foscarnet Sodium Injection
The Board at its meeting held today, May 14, 2026, had declared Interim Dividend of INR.4.00 (200%) per equity share for the FY 2025-26 and fixed the Record date as May 30, 2026.
Financial Results for the Quarter and Year ended March 31, 2026
The Board at its meeting held today, May 14, 2026, had 1. Approved the Audited standalone and consolidated financial results of the Company for the year ended March 31, 2026, along with Auditors Report. 2. Declared an Interim Dividend of INR. 4.00 (200 %) per equity share and fixed the record date as May 30, 2026 3. Approved amendments to Code of Practices and Procedure for Fair Disclosure of Unpublished Price Sensitive Information
Q4 post-results conference call invite is enclosed herewith.
Audited financial results of the Company for the year ended March 31, 2026 (both Standalone & Consolidated) and declaration of Interim Dividend, if any, for the FY 2025-26
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 173.66 | 179.22 | 132.83 | 139.38 | 185.64 | 207.93 | 185.23 | 173.61 | 182.57 | 175.18 | 189.22 | 191.36 |
| YOY Revenue Growth % | 49.21% | 30.87% | 1.71% | -3.66% | 6.9% | 16.02% | 39.45% | 24.56% | -1.65% | -15.75% | 2.15% | 10.22% |
| Other Income | 27.27 | 24.49 | 17.90 | 36.18 | 21.50 | 43.01 | 28.83 | 41.25 | 32.03 | 59.22 | 31.73 | 61.08 |
| Total Income | 200.93 | 203.71 | 150.73 | 175.56 | 207.14 | 250.94 | 214.06 | 214.86 | 214.60 | 234.40 | 220.95 | 252.44 |
| Total Expenses + | 103.74 | 96.51 | 76.29 | 88.65 | 110.46 | 116.28 | 113.89 | 104.70 | 102.14 | 105.40 | 103.94 | 114.72 |
| Cost of Materials Consumed | 42.68 | 45.84 | 43.43 | 40.18 | 36.38 | 32.72 | 33.29 | 34.25 | 38.62 | 34.92 | 39.47 | 45.80 |
| Employee Benefit Expense | 9.72 | 9.10 | 9.52 | 9.77 | 10.86 | 12.99 | 13.89 | 14.39 | 9.63 | 11.54 | 13.41 | 13.15 |
| Other Expenses | 23.59 | 24.23 | 18.44 | 28.43 | 33.03 | 35.00 | 33.23 | 28.88 | 28.26 | 29.61 | 26.97 | 39.04 |
| Operating Profit | 69.92 | 82.71 | 56.54 | 50.73 | 75.18 | 91.65 | 71.34 | 68.91 | 80.43 | 69.78 | 85.28 | 76.64 |
| OPM % | 40.3% | 46.1% | 42.6% | 36.4% | 40.5% | 44.1% | 38.5% | 39.7% | 44.1% | 39.8% | 45.1% | 40.1% |
| Profit Before Tax + | 97.19 | 107.20 | 74.43 | 86.91 | 96.68 | 134.66 | 100.17 | 110.16 | 112.46 | 129.00 | 117.01 | 137.72 |
| Tax Expense | 20.92 | 25.10 | 18.98 | 17.03 | 24.14 | 28.92 | 25.46 | 23.66 | 26.57 | 26.41 | 29.73 | 28.22 |
| Tax % | 21.5% | 23.4% | 25.5% | 19.6% | 25% | 21.5% | 25.4% | 21.5% | 23.6% | 20.5% | 25.4% | 20.5% |
| Profit After Tax | 76.27 | 82.10 | 55.45 | 69.88 | 72.54 | 105.74 | 74.71 | 86.50 | 85.89 | 102.59 | 87.28 | 109.50 |
| EPS (Basic) | 10.04 | 10.82 | 7.30 | 9.20 | 9.55 | 13.92 | 9.83 | 11.37 | 11.30 | 13.50 | 11.49 | 15.89 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 738.33 | 752.41 | 625.09 | 528.61 | 528.06 | 482.68 | 527.83 |
| YOY Revenue Growth % | -1.87% | 20.37% | 18.25% | 0.1% | 9.4% | -8.55% | - |
| Other Income | 195.37 | 134.59 | 105.84 | 99.00 | 56.55 | 18.62 | 65.97 |
| Total Income | 933.70 | 887.00 | 730.93 | 627.61 | 584.61 | 501.30 | 593.80 |
| Total Expenses + | 426.18 | 445.33 | 365.19 | 334.46 | 334.30 | 291.36 | 178.39 |
| Cost of Materials Consumed | 158.82 | 136.64 | 172.13 | 151.35 | 156.01 | 112.48 | 95.73 |
| Employee Benefit Expense | 47.72 | 52.13 | 38.11 | 36.68 | 30.47 | 26.59 | 25.00 |
| Other Expenses | 123.87 | 130.14 | 94.68 | 73.95 | 73.32 | 47.33 | 57.66 |
| Operating Profit | 312.15 | 307.08 | 259.90 | 194.15 | 193.76 | 191.32 | 349.44 |
| OPM % | 42.3% | 40.8% | 41.6% | 36.7% | 36.7% | 39.6% | 66.2% |
| Profit Before Exceptional | 507.52 | 441.67 | 365.74 | 293.15 | 250.31 | 209.94 | 253.12 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 507.52 | 441.67 | 365.74 | 293.15 | 250.31 | 209.94 | 253.12 |
| Tax Expense | 110.94 | 102.18 | 82.03 | 58.89 | 62.44 | 53.71 | 55.49 |
| Tax % | 21.9% | 23.1% | 22.4% | 20.1% | 24.9% | 25.6% | 21.9% |
| Profit After Tax | 396.58 | 339.49 | 283.71 | 234.26 | 187.87 | 156.23 | 197.64 |
| EPS (Basic) | 52.17 | 44.67 | 37.36 | 30.89 | 24.82 | 20.65 | 26.13 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Non-Current Assets + | 1,235.86 | 988.79 | 819.81 | 639.20 | 448.49 | 328.34 | 0.00 |
| Property, Plant & Equipment | 219.68 | 201.59 | 161.77 | 151.70 | 157.50 | 177.93 | 0.00 |
| Capital Work in Progress | 9.39 | 20.64 | 27.75 | 42.68 | 1.73 | 1.36 | 0.00 |
| Non-Current Investments | 704.73 | 491.11 | 346.17 | 274.97 | 212.73 | 0.66 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 3.24 | 2.10 | 3.17 | 3.94 | 4.47 | 3.60 | 0.00 |
| Current Assets + | 975.88 | 825.69 | 702.50 | 663.98 | 605.67 | 532.66 | 0.00 |
| Inventories | 85.66 | 66.26 | 86.25 | 51.53 | 42.81 | 24.87 | 0.00 |
| Trade Receivables | 265.96 | 175.33 | 128.67 | 88.24 | 53.73 | 98.46 | 0.00 |
| Cash and Cash Equivalents | 44.09 | 99.64 | 80.64 | 122.02 | 81.01 | 148.82 | 0.00 |
| Current Investments | 342.51 | 311.33 | 237.98 | 159.17 | 51.97 | 10.54 | 0.00 |
| LIABILITIES & EQUITY | |||||||
| Total Equity | 2,050.50 | 1,700.93 | 1,390.15 | 1,139.91 | 930.65 | 758.68 | 0.00 |
| Equity Share Capital | 15.20 | 15.20 | 15.19 | 15.18 | 15.16 | 15.13 | 0.00 |
| Other Equity | 2,035.30 | 1,685.73 | 1,374.96 | 1,124.73 | 915.49 | 743.55 | 0.00 |
| Non-Current Liabilities | 17.07 | 13.70 | 12.86 | 16.42 | 24.63 | 24.99 | 0.00 |
| Current Liabilities | 144.17 | 99.85 | 119.30 | 146.85 | 98.88 | 77.33 | 0.00 |
| Total Liabilities | 161.24 | 113.55 | 132.16 | 163.27 | 123.51 | 102.32 | 0.00 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activities | 214.78 | 195.87 | 104.21 | 157.10 | 230.97 | 294.64 | 0.00 |
| Cash from Investing Activities | -224.77 | -140.20 | -112.14 | -86.67 | -237.18 | 16.29 | 0.00 |
| Cash from Financing Activities | -45.81 | -38.10 | -34.26 | -30.42 | -22.76 | -3.47 | 0.00 |
| Net Increase/Decrease in Cash | -55.55 | 17.57 | -41.38 | 41.01 | -29.06 | 307.27 | 0.00 |